Enhanced differentiation between 3-hydroxyglutaric and 2-hydroxyglutaric acids facilitates diagnostic testing for...

Area of Science:

• Biochemistry
• Metabolic Disorders
• Analytical Chemistry

Background:

• Glutaric aciduria type 1 (GA1) is an inherited neurometabolic disorder.
• Accurate quantitation of urinary 3-hydroxyglutaric acid (3-HG) is critical for GA1 diagnosis, especially in low excretors.
• Current gas chromatography-mass spectrometry (GC-MS) methods face challenges in differentiating 3-HG from its isomer 2-HG due to co-elution and spectral similarities.

Purpose of the Study:

• To develop and validate an improved method for accurate quantitation of urinary 3-HG in GA1 diagnosis.
• To leverage the sensitivity and specificity of gas chromatography-tandem mass spectrometry (GC-MS/MS) to overcome limitations of existing GC-MS methods.
• To enhance the efficiency and reduce the resource requirements for GA1 diagnostic testing.

Main Methods:

• Utilized a gas chromatography system coupled to a triple quadrupole mass spectrometer (GC-MS/MS).
• Employed a stable isotope dilution process with double liquid-liquid extraction and trimethylsilyl derivatization.
• Selected specific mass transitions (m/z 349→333 for 3-HG, m/z 349→321 for 2-HG) to differentiate isobaric molecules.

Main Results:

• The GC-MS/MS method demonstrated satisfactory precision and accuracy for 3-HG quantitation.
• The assay successfully minimized interferences from 2-HG despite co-elution.
• Implementation of GC-MS/MS led to reduced specimen volume, fewer processing steps, shorter run times, and decreased instrument maintenance.

Conclusions:

• The enhanced GC-MS/MS assay provides a more sensitive and specific method for quantifying urinary 3-HG.
• This improved assay facilitates accurate diagnosis and management of Glutaric aciduria type 1.
• The method is suitable for confirmatory testing after newborn screening and for diagnostic investigations in symptomatic patients.